BIND Doses First Patient in a Phase 2 Clinical Study of BIND-014 in Non-small Cell Lung Cancer

"There are limited options for patients with advanced non-small cell lung cancer in the second-line setting.

http://eon.businesswire.com/news/eon/20130729005337/en/BIND-Doses-Patient-Phase-2-Clinical-Study